Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds

Date:

Share post:




Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer greater benefits than just weight and diabetes management.



Source link

Alexandra Williams
Alexandra Williams
Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Recent posts

Related articles

Trump tariffs: These states would be hit hardest by proposed import taxes

Donald Trump’s most controversial economic-policy proposal is to institute a 10% tariff on all products and materials...

Uber reportedly weighed buying Expedia. Analysts have reservations.

Shares of Expedia Group Inc. rallied after the Financial Times on Wednesday reported that ride-hailing giant Uber...

Oil prices find a floor after 4-day slide despite disappointing Chinese stimulus

Crude futures appeared to stabilize on Thursday, trading modestly higher after sliding for four sessions. But skepticism...

Elevance Health’s stock tumbles as profit dented by ‘unprecedented’ Medicaid challenges

“We remain confident in the long-term earnings potential of our diverse businesses as we navigate a dynamic...

Bond investors position for new debt from Goldman Sachs and Morgan Stanley

Bond investors — who have sent spreads on the debt of the big U.S. money-center banks to...

Parents trust Republicans more on the economy, but they’re split on Trump vs. Harris

In a survey by the National Parents Union, more parents said they trust the Republican party to...

ASML says chip-market slump will mainly impact sales to China

A day after a profit warning that rocked the stock market, executives at ASML Holding said the...

Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical...